Astera Labs beats Q3 estimates and guides for strong Q4 growth

Astera Labs reported third-quarter non-GAAP EPS of $1.32 and revenue of $584.9M, which was up 153.6% year over year and exceeded estimates. For the fourth quarter of fiscal 2026, the company forecast revenue of $730 million to $750 million and non-GAAP diluted EPS of $1.62 to $1.66, with growth expected from Scorpio, Aries and Taurus products.

The Q4 outlook implies a sharp sequential revenue increase and gives investors updated benchmarks for Astera Labs' product expansion. The company also expects non-GAAP gross margin of about 72% and non-GAAP operating margin of approximately 45% in Q4.

  • 1Astera Labs reported Q3 non-GAAP EPS of $1.32, beating estimates by $0.13.
  • 2Q3 revenue was $584.9M, up 153.6% year over year.
  • 3The company forecast Q4 revenue of $730 million to $750 million, with the midpoint representing 27% sequential growth.
  • 4Astera Labs guided to Q4 non-GAAP diluted EPS of $1.62 to $1.66.
  • 5Q3 revenue was up 49% sequentially, according to the company’s earnings report.

Sources